Martin Kiernan on Muck Rack

Martin Kiernan

England
As seen in: Infection Control Matters, Cambridge University Press & Assessment, Memory Studies, PLOS, The Lancet, Law360, JD Supra, The Journal of Hospital Infection, Law360 UK, Infection, Disease & Health
Uni West London, Uni of Newcastle (NSW), Avondale Uni (NSW) and 'Infection Control Matters' podcast
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Martin

Contact Martin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

HIS Early Career Award: Surface contamination, MRSA, CPE, and the future of IPC

|
By Jon Otter, Martin Kiernan, Andreas Voss
| reflectionsipc.com
I was delighted to spend a day at the FIS International 2025 conference in Bournemouth this week to collect my HIS Early Career Award. I had a the honour of an award lecture – you can download my slides here.
Open in Who Shared Issue with article?

Dry surface biofilms explain extraordinary survival properties of Enterococcus

|
By Jon Otter, Martin Kiernan, Andreas Voss
| reflectionsipc.com
We know that many vegetive bacteria can survive on dry surfaces for . For some Enterococcus species, this capability is nothing short of extraordinary. In one study, Enterococcus dried onto a surface was still viable 4 years (yes FOUR YEARS) later! How can this be? No nutrients, no water (other than ambient humidity), and not an endospore former.
Open in Who Shared Issue with article?

ESPAUR 2025: antibacterial resistance and the emergence of Candidozyma auris in England

|
By Jon Otter, Martin Kiernan, Andreas Voss
| reflectionsipc.com
The latest ESPAUR report (2024–2025) paints a sobering picture of AMR in England. While prescribing practices have improved in some areas, the resistant infections are increasing, and new threats like Candidozyma auris are emerging. It’s always a treat to read, and reminds me what a privilege it is to work in a part of the world with such strong national surveillance systems.
Open in Who Shared Issue with article?
See all 115 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified